NLM Logo

valrubicin MeSH Supplementary Concept Data 2023


MeSH Supplementary
valrubicin
Unique ID
C016163
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C016163
Entry Term(s)
(2S-cis)-pentanoic acid, 2-(1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-4-((2,3,6-trideoxy-3-((trifluoroacetyl)amino)-alpha-L-lyxo-hexopyranosyl)oxy)-2-naphth acenyl)-2-oxoethyl ester
AD 32
AD-32
N-trifluoroacetyladriamycin 14-valerate
NSC-246131
Valstar
Valtaxin
adriamycin, trifluoroacetyl-, 14-valerate
Pharm Action
Antineoplastic Agents
Topoisomerase II Inhibitors
Registry Number
2C6NUM6878
Related Numbers
56124-62-0
Heading Mapped to
Doxorubicin / *analogs & derivatives
Frequency
83
Source
Cancer Res 38(11):3944;1978
Cancer Res 39(2):360;1979
Cancer Res 39(2):448;1979
Cancer Treat Rep 62(1):105-19;1978
Cancer Treat Rep 63(5):875;1979
Cancer Treat Rep 63(5):919;1979
J Histochem Cytochem 1979;27(12):1655
J Natl Cancer Inst 61(6):1521;1978
J Pharmacol Exp Ther 204(3):696;1978
Date of Entry
1978/01/01
Revision Date
2022/09/02
valrubicin Preferred
Valtaxin Narrower
Valstar Narrower
AD 32 Narrower
NSC-246131 Narrower
page delivered in 0.007s